Outer membrane vesicle vaccines
Outer Membrane Vesicles (OMV) have received increased attention in recent years as a vaccine platform against bacterial pathogens. OMV from Neisseria meningitidis serogroup B have been extensively explored. Following the success of the MeNZB OMV vaccine in controlling an outbreak of N. meningitidis...
Prif Awduron: | Micoli, F, MacLennan, CA |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Elsevier
2020
|
Eitemau Tebyg
-
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1
gan: Marini, A, et al.
Cyhoeddwyd: (2017) -
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella
gan: Micoli, F, et al.
Cyhoeddwyd: (2018) -
Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
gan: Arianna Marini, et al.
Cyhoeddwyd: (2017-01-01) -
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines
gan: Francesca Micoli, et al.
Cyhoeddwyd: (2023-05-01) -
Outer Membrane Vesicles: An Emerging Vaccine Platform
gan: Dharmendra Kashyap, et al.
Cyhoeddwyd: (2022-09-01)